{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:44:43Z","timestamp":1769103883933,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Technology","award":["102-2622-B-400-001-CC2"],"award-info":[{"award-number":["102-2622-B-400-001-CC2"]}]},{"name":"Ministry of Science and Technology","award":["103-2622-B-400-001-CC2"],"award-info":[{"award-number":["103-2622-B-400-001-CC2"]}]},{"name":"Ministry of Science and Technology","award":["102-2321-B-400-022"],"award-info":[{"award-number":["102-2321-B-400-022"]}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"crossref","award":["IV-105-PP-25"],"award-info":[{"award-number":["IV-105-PP-25"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2017.03.016","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T16:20:10Z","timestamp":1490199610000},"page":"3146-3152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography"],"prefix":"10.1016","volume":"36","author":[{"given":"Yu-Fen","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Chuan","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Shi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan Yung-Chih","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.016_b0005","first-page":"S2-9","article-title":"Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses","volume":"13 Suppl. 1","author":"Uyeki","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.vaccine.2017.03.016_b0010","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1056\/NEJMoa0903810","article-title":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans","volume":"360","author":"Dawood","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.03.016_b0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.meegid.2014.10.016","article-title":"Avian influenza A (H7N9) virus infection in humans: epidemiology, evolution, and pathogenesis","volume":"28","author":"Husain","year":"2014","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2017.03.016_b0020","first-page":"431","article-title":"Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting","volume":"73","author":"World Health Organization","year":"1995","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.03.016_b0025","unstructured":"Executive Office of the President, PCAST, USA. Report to the president on reengineering the influenza vaccine production enterprise to meet the challenges of pandemic influenza; 2010."},{"key":"10.1016\/j.vaccine.2017.03.016_b0030","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ceat.200800118","article-title":"Downstream processing: from egg to cell culture-derived influenza virus particles","volume":"31","author":"Wolff","year":"2008","journal-title":"Chem Eng Technol"},{"key":"10.1016\/j.vaccine.2017.03.016_b0035","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/bit.25545","article-title":"Improved virus purification processes for vaccines and gene therapy","volume":"112","author":"Nestola","year":"2015","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2017.03.016_b0040","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/j.chroma.2011.04.086","article-title":"Reduced surface area chromatography for flow-through purification of viruses and virus like particles","volume":"1218","author":"Iyer","year":"2011","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2017.03.016_b0045","first-page":"17","article-title":"Egg-based production of influenza vaccine: 30 years of commercial experience","volume":"36","author":"Matthews","year":"2006","journal-title":"The Bridge"},{"key":"10.1016\/j.vaccine.2017.03.016_b0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00253-004-1874-1","article-title":"Influenza vaccines: recent advances in production technologies","volume":"67","author":"Bardiya","year":"2005","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.016_b0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jviromet.2008.09.004","article-title":"Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent","volume":"154","author":"Opitz","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2017.03.016_b0060","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1016\/j.chroma.2011.06.043","article-title":"Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium","volume":"1218","author":"He","year":"2011","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2017.03.016_b0065","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/bit.22345","article-title":"Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles","volume":"103","author":"Opitz","year":"2009","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2017.03.016_b0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1348-0421.2012.00468.x","article-title":"Purification of human and avian influenza viruses using cellulose sulfate ester (Cellufine Sulfate) in the process of vaccine production","volume":"56","author":"Sakoda","year":"2012","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.03.016_b0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.memsci.2007.04.048","article-title":"Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers","volume":"299","author":"Kalbfuss","year":"2007","journal-title":"J Memb Sci"},{"key":"10.1016\/j.vaccine.2017.03.016_b0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jbiotec.2015.12.022","article-title":"A membrane-based purification process for cell culture-derived influenza A virus","volume":"220","author":"Weigel","year":"2016","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.016_b0085","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.vaccine.2014.02.086","article-title":"Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography","volume":"32","author":"Banjac","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.016_b0090","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1016\/j.vaccine.2014.09.074","article-title":"Preparation of pure, high titer, pseudo infectious Flavivirus particles by hollow fiber tangential flow filtration and anion exchange chromatography","volume":"33","author":"Mundle","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.016_b0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jbiotec.2007.07.723","article-title":"Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses","volume":"131","author":"Opitz","year":"2007","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.016_b0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.procbio.2014.02.018","article-title":"Negative chromatography: progress, applications and future perspectives","volume":"49","author":"Lee","year":"2014","journal-title":"Process Biochem"},{"key":"10.1016\/j.vaccine.2017.03.016_b0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1021\/bp050274w","article-title":"Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification","volume":"22","author":"Yigzaw","year":"2006","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2017.03.016_b0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chroma.2015.08.056","article-title":"Negative chromatography purification of hepatitis B virus-like particles using poly(oligo(ethylene glycol) methacrylate) grafted cationic adsorbent","volume":"1415","author":"Lee","year":"2015","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2017.03.016_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2016.03.066","article-title":"Negative chromatography of hepatitis B virus-like particle: comparative study of different adsorbent designs","volume":"1445","author":"Lee","year":"2016","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2017.03.016_b0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chroma.2004.03.050","article-title":"Purification of plasmid DNA with a new type of anion-exchange beads having a non-charged surface","volume":"1038","author":"Gustavsson","year":"2004","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2017.03.016_b0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.provac.2012.04.015","article-title":"Flow-THROUGH PURIFICATION OF VIRUSES - A NOVEL APPROACH TO VACCINE PURIFICATION","volume":"6","author":"Iyer","year":"2012","journal-title":"Proc Vaccinol"},{"key":"10.1016\/j.vaccine.2017.03.016_b0130","unstructured":"GE Healthcare. Purification of influenza A\/H1N1 using Capto TM Core 700.Appl Note 29-0003-34 AA; 2012."},{"key":"10.1016\/j.vaccine.2017.03.016_b0135","unstructured":"GE Healthcare. Downstream scale-up purification of influenza virus using Ready To Process equipment. Appl Note 29-0435-49 AA; 2013."},{"key":"10.1016\/j.vaccine.2017.03.016_b0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.chroma.2015.11.037","article-title":"Rational development of two flowthrough purification strategies for adenovirus type 5 and retro virus-like particles","volume":"1426","author":"Nestola","year":"2015","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2017.03.016_b0145","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.vaccine.2016.04.024","article-title":"Core bead chromatography for preparation of highly pure, infectious respiratory syncytial virus in the negative purification mode","volume":"34","author":"Mundle","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.016_b0150","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1016\/j.vaccine.2014.04.033","article-title":"Efficient chromatographic reduction of ovalbumin for egg-based influenza virus purification","volume":"32","author":"Blom","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.016_b0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jviromet.2014.06.019","article-title":"A flow-through chromatography process for influenza A and B virus purification","volume":"207","author":"Weigel","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2017.03.016_b0160","unstructured":"European Pharmacopeia. Influenza vaccine (whole virion, inactivated, prepared in cell cultures). Eur Dir Qual Med 2012; 7.8."},{"key":"10.1016\/j.vaccine.2017.03.016_b0165","unstructured":"Lee MS, Chen YS, Tseng YF, Chong CS. Vero cell-based influenza virus strains and vaccines. Patent No. US7931906B2; 2011."},{"key":"10.1016\/j.vaccine.2017.03.016_b0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biologicals.2007.10.002","article-title":"Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity","volume":"36","author":"Kalbfuss","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2017.03.016_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2017.03.016_b0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.chroma.2014.04.079","article-title":"Adenovirus purification by two-column, size-exclusion, simulated countercurrent chromatography","volume":"1347","author":"Nestola","year":"2014","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2017.03.016_b0185","unstructured":"Invitrogen, Thermo-Fisher. Comparison of Quant-iT and Qubit DNA quantitation assays for accuracy and precision. Appl Note; 2016."},{"key":"10.1016\/j.vaccine.2017.03.016_b0190","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jpba.2009.01.022","article-title":"Development and characterization of a novel host cell DNA assay using ultra-sensitive fluorescent nucleic acid stain \u201cPicoGreen\u201d","volume":"49","author":"Ikeda","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.vaccine.2017.03.016_b0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biologicals.2007.11.003","article-title":"Oncogenicity of DNA in vivo: tumor induction with expression plasmids for activated H-ras and c-myc","volume":"36","author":"Sheng","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2017.03.016_b0200","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biologicals.2009.02.015","article-title":"Issues associated with residual cell-substrate DNA in viral vaccines","volume":"37","author":"Sheng-Fowler","year":"2009","journal-title":"Biologicals"},{"issue":"10","key":"10.1016\/j.vaccine.2017.03.016_b0205","doi-asserted-by":"crossref","first-page":"e0120793","DOI":"10.1371\/journal.pone.0120793","article-title":"Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets","volume":"2015","author":"Chia","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T09:00:48Z","timestamp":1535965248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":41,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X17303225"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}